General Information of Drug (ID: DMSBHSX)

Drug Name
GL-0810
Synonyms
912762-45-9; GL-0810; tert-Butyl (2-(hydroxyimino)-2-phenylethyl)carbamate; tert-butyl N-[(2Z)-2-(hydroxyimino)-2-phenylethyl]carbamate; (2-HYDROXYIMINO-2-PHENYL-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER; MolPort-002-506-758
Indication
Disease Entry ICD 11 Status REF
Squamous cell carcinoma 2B60-2D01 Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C13H18N2O3
Canonical SMILES
CC(C)(C)OC(=O)NCC(=NO)C1=CC=CC=C1
InChI
1S/C13H18N2O3/c1-13(2,3)18-12(16)14-9-11(15-17)10-7-5-4-6-8-10/h4-8,17H,9H2,1-3H3,(H,14,16)/b15-11+
InChIKey
OYCHXXYYNVNOEE-RVDMUPIBSA-N
Cross-matching ID
PubChem CID
16740551
CAS Number
912762-45-9
TTD ID
D0F6ZT

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035080)